These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16215448)

  • 41. The effect of bupropion sustained-release on cigarette craving after smoking cessation.
    Durcan MJ; Deener G; White J; Johnston JA; Gonzales D; Niaura R; Rigotti N; Sachs DP
    Clin Ther; 2002 Apr; 24(4):540-51. PubMed ID: 12017399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of pharmacotherapies for smoking cessation during pregnancy.
    Benowitz NL; Dempsey DA; Goldenberg RL; Hughes JR; Dolan-Mullen P; Ogburn PL; Oncken C; Orleans CT; Slotkin TA; Whiteside HP; Yaffe S
    Tob Control; 2000; 9 Suppl 3(Suppl 3):III91-4. PubMed ID: 10982920
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis.
    Wagena EJ; Knipschild P; Zeegers MP
    Addiction; 2005 Mar; 100(3):317-26. PubMed ID: 15733245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness analysis of the first-line therapies for nicotine dependence.
    Cornuz J; Pinget C; Gilbert A; Paccaud F
    Eur J Clin Pharmacol; 2003 Jul; 59(3):201-6. PubMed ID: 12759795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression.
    Wagena EJ; Huibers MJ; van Schayck CP
    Thorax; 2001 Aug; 56(8):587-8. PubMed ID: 11462058
    [No Abstract]   [Full Text] [Related]  

  • 47. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009670. PubMed ID: 23235680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term mental health resource utilization and cost of care following group psychoeducation or unstructured group support for bipolar disorders: a cost-benefit analysis.
    Scott J; Colom F; Popova E; Benabarre A; Cruz N; Valenti M; Goikolea JM; Sánchez-Moreno J; Asenjo MA; Vieta E
    J Clin Psychiatry; 2009 Mar; 70(3):378-86. PubMed ID: 19284929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacologic therapy for nicotine addiction.
    DeGraff AC
    Chest; 2002 Aug; 122(2):392-4. PubMed ID: 12171803
    [No Abstract]   [Full Text] [Related]  

  • 50. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
    Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bupropion to aid smoking cessation.
    Drug Ther Bull; 2000 Oct; 38(10):73-5. PubMed ID: 11127161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Methods and cost effectiveness of nicotine abstinence].
    Górecka D
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():79-82. PubMed ID: 15524024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nortriptyline for smoking cessation: a review.
    Hughes JR; Stead LF; Lancaster T
    Nicotine Tob Res; 2005 Aug; 7(4):491-9. PubMed ID: 16085520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antidepressants for smoking cessation.
    Hughes JR; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2003; (2):CD000031. PubMed ID: 12804385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
    Bolin K; Lindgren B; Willers S
    Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation.
    Zernig G; Wallner R; Grohs U; Kriechbaum N; Kemmler G; Saria A
    Addiction; 2008 Dec; 103(12):2024-31. PubMed ID: 19469746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.
    Domino ME; Foster EM; Vitiello B; Kratochvil CJ; Burns BJ; Silva SG; Reinecke MA; March JS
    J Am Acad Child Adolesc Psychiatry; 2009 Jul; 48(7):711-720. PubMed ID: 19465880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Smoking cessation treatment outcomes among people with and without mental and substance use disorders: An observational real-world study.
    Castaldelli-Maia JM; Loreto AR; Guimarães-Pereira BBS; Carvalho CFC; Gil F; Frallonardo FP; Ismael F; Andrade AG; Ventriglio A; Richter KP; Bhugra D
    Eur Psychiatry; 2018 Aug; 52():22-28. PubMed ID: 29609056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anxiolytics and antidepressants for smoking cessation.
    Hughes JR; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2000; (2):CD000031. PubMed ID: 10796472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.